Background Stroke is the third leading cause of death and disability worldwide accounting
for 400-800 strokes per 100,000 individuals each year. Purpose In the present study, we …

Methods: A total of 104 patients with AIS were enrolled for the study. Clinical outcome and
stroke biomarker levels were evaluated in them at the time of hospital discharge and then …

Purpose MMP-9 is reported to be a marker of severity and worse outcome after stroke. Despite
the above information, there are very few studies based on the evaluation of role of follow-…

Materials and Methods Hundred and four patients admitted to Neurology department of
Central India Institute of Medical Sciences were grouped as early referrals (within 24 hour …

Background: Differential diagnosis of Ischemic stroke (IS) and Hemorrhagic Stroke (HS) patient
is crucial for augmenting the specific treatment. Objective: In the present study, we aimed …

Here we compare the in-house ELISA technique for estimation of neuron-specific enolase (NSE)
and S-100ββ (glial-specific protein) peptides with a commercial kit in serum samples of …

In the present study, we assessed the demographic and clinical factors that affect mortality
and functional outcome in acute ischemic stroke (AIS) patients at the time of hospital …

… thanks the panelists and Professor Lande for their engaging discussions and insight on both
pressing issues within antitrust law and the career of Professor Lande. We also extend our …

Background: Demographic and clinical characteristics are known to influence the outcome
in acute ischemic stroke (AIS) patients. Purpose: This study is aimed at evaluating short- and …

… jedoch seine auf lange Sicht eintretenden Folgen eine hinreichende Modernisierung des
Anlagekapitals im Lande verhinderten und so dazu beitrugen, das Wachstum zu blockieren. …